Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The SIRT6 gene encodes Sirtuin 6 and is located on human chromosome 19p13.3. It is a member of the sirtuin family of NAD⁺-dependent deacetylases (SIRT1–SIRT7). All family members share a conserved NAD⁺-binding catalytic domain but differ in subcellular localization and substrate specificity. SIRT6 is primarily localized in the nucleus and tightly associates with chromatin. Compared to classical class III histone deacetylases, SIRT6 exhibits relatively weak histone deacetylase activity but possesses robust ADP-ribosyltransferase activity and long-chain fatty acyl deacylase activity. SIRT6 is widely expressed across multiple tissues, and its activity is regulated by NAD⁺ levels, nutritional status, and cellular stress. Transcriptional and post-translational modifications, such as phosphorylation and SUMOylation, together establish a finely tuned regulatory network for SIRT6.
Figure 1. SIRT6 promotes fatty acid oxidation by multiple mechanisms. (Dong XC. 2023)
SIRT6 is a key regulator of genomic stability, metabolic homeostasis, and aging. In DNA damage repair, SIRT6 is rapidly recruited to sites of DNA double-strand breaks, where it deacetylates H3K9 and H3K56, facilitating the recruitment of critical proteins for non-homologous end joining (NHEJ) and homologous recombination (HR), thereby efficiently initiating repair. SIRT6 also deacetylates non-histone substrates such as DDB2 and p53, further coordinating the repair process. In telomere maintenance, SIRT6 preserves telomeric heterochromatin integrity by regulating H3K9ac and H3K56ac, preventing aberrant chromosomal end structures.
In metabolic regulation, SIRT6 functions as a negative regulator of glycolysis and lipid metabolism. It acts as a co-repressor of HIF1α to suppress glycolysis-related gene expression and directly deacetylates PKM2 to inhibit its activity, thereby restraining the Warburg effect in tumor cells. In the liver, SIRT6 deacetylates FOXO1 and GCN5 to inhibit gluconeogenesis, while modulating PPARGC1α and NCOA2 to promote fatty acid β-oxidation and suppress lipogenesis. Its de-fatty-acylation activity regulates the membrane localization and secretion of Ras-related protein RRAS2 and TNF, influencing signaling and inflammatory responses. Additionally, SIRT6 regulates gene silencing and chromatin structure via ADP-ribosylation of KAP1 and BAF170. Collectively, SIRT6 integrates energy metabolism, stress responses, and epigenetic regulation through multiple enzymatic activities, providing a molecular basis for delaying aging and maintaining healthspan.
Figure 2. SIRT6 promotes fatty acid oxidation by multiple mechanisms. (Dong XC. 2023)
SIRT6 plays a critical role in aging and age-related diseases. Studies in model organisms have shown that SIRT6 overexpression extends lifespan and mitigates age-associated pathologies, making it a promising target for anti-aging interventions. In metabolic disorders, SIRT6 deficiency is associated with obesity, insulin resistance, and type 2 diabetes, and enhancing SIRT6 activity is considered a potential strategy to improve metabolic health and treat MASLD. In the cardiovascular system, SIRT6 inhibits endothelial inflammation, delays vascular calcification, and attenuates cardiac hypertrophy, protecting against atherosclerosis and heart failure.
In oncology, SIRT6 generally functions as a tumor suppressor by inhibiting glycolysis and maintaining genomic stability, though it may exhibit context-dependent pro-survival effects. Downregulation of SIRT6 correlates with poor prognosis in colorectal, liver, and pancreatic cancers, suggesting that restoring SIRT6 function could be a novel anticancer strategy. In neurodegenerative disease models, SIRT6 demonstrates neuroprotective effects, potentially via DNA repair, attenuation of neuroinflammation, and modulation of energy metabolism.
Challenges in clinical translation mainly involve developing specific SIRT6 activators. Candidate molecules such as UBCS039 have shown preclinical potential, but their potency and specificity require optimization. Moreover, the long-term safety and potential off-target effects of systemic SIRT6 activation must be carefully evaluated. Future research will focus on tissue-specific delivery or targeting downstream effectors. As a central molecule linking metabolism, DNA repair, and aging, SIRT6 activator development holds promise for treating age-related diseases.
References
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.